Europe Laboratory Information System Market
Marktgröße in Milliarden USD
CAGR :
%
USD
417.21 Million
USD
803.44 Million
2024
2032
| 2025 –2032 | |
| USD 417.21 Million | |
| USD 803.44 Million | |
|
|
|
|
Europe Laboratory Information Systems (LIS) Marktsegmentierung, Von Komponente (Service and Software), Produkt (Integrated LIS and Standalone LIS), Lieferung (Cloud-basiert, remote-Hosted, and On-Premise), Endbenutzer (Hospital Laboratories, Independent Laboratories, Physician Office Laboratories, and Others) - Branchentrends und Prognose bis 2032
Europe Laboratory Information Systems (LIS) Market Size
- The Europe laboratory information systems (LIS) market size was valued atUSD 412.21 billion in 2024and is expected to reachUSD 803.44 million by 2032, at aCAGR of 8.70 %during the forecast period
- This growth is driven by factors such as the increasing demand for accurate and timely test results, growing adoption of electronic health records (EHR), and rising government initiatives to digitize healthcare systems
Europe Laboratory Information Systems (LIS) Market Analysis
-
The laboratory information systems market is experiencing significant growth as healthcare facilities increasingly shift toward digitalization, enhancing laboratory data management and workflow efficiency
- Integration of advanced technologies such asartificial intelligenceand machine learning into laboratory information systems is expected to improve diagnostic accuracy and streamline operations
- Germany is expected to dominate the Europe Laboratory Information Systems (LIS)s market due to advanced healthcare infrastructure, high adoption rate of innovative technologies, and leading role in digitalizing healthcare processes
- Germany is expected to be the fastest growing region in the Europe Laboratory Information Systems (LIS) market during the forecast period due to strong focus on technological innovation, coupled with the rapid integration of digital solutions in healthcare facilities
- Cloud-based segment is expected to dominate the market with a market share of 44.3% due to its scalability, cost-effectiveness, and ability to provide remote access to laboratory data
Report Scope and Europe Laboratory Information Systems (LIS) Market Segmentation
|
Attributes |
Europe Laboratory Information Systems (LIS) KeyMarket Insights |
|
Segments Covered |
|
|
Countries Covered |
Europe
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Europe Laboratory Information Systems (LIS) Market Trends
“Increasing Adoption of Cloud-Based Solutions”
- One noticeable trend in the Europe laboratory information systems market is the increasing adoption of cloud-based solutions
- Cloud-based laboratory information systems offer enhanced data storage, collaboration, and real-time access to information, which are critical in a highly regulated environment
- For instance, LabWare's cloud-based LIS solutions provide improved security, compliance, scalability, and reduced IT manpower needs, benefiting laboratories in navigating complexities while focusing on core operations
- Similarly, Thermo Fisher Scientific's cloud-based LIS platforms enable laboratories to streamline operations and improve patient care by leveraging cloud computing technologies
Europe Laboratory Information Systems (LIS) Market Dynamics
Driver
“Increasing Demand for Enhanced Data Management and Efficiency in Healthcare Facilities”
- One of the key drivers of the Europe Laboratory Information Systems (LIS) market is the increasing demand for enhanced data management and efficiency in healthcare facilities
- The growing volume of medical data generated from laboratory tests requires systems that can manage, store, and analyze data effectively
- Traditional manual methods are becoming insufficient, and LIS systems offer streamlined data management that reduces errors and improves turnaround times for test results
- For instance, hospitals such as the University of Edinburgh Medical School have integrated LIS to enhance data storage and streamline test result reporting, improving efficiency
- The integration of LIS with other healthcare systems, such as Electronic Health Records (EHR), ensures laboratory results are easily accessible and accurate, leading to better patient care
- For instance, collaboration between Cerner and various healthcare providers across Europe, which integrates LIS with EHR for seamless patient care management
- The growing demand for personalized medicine, which requires precise and quick data analysis, further boosts the adoption of LIS in healthcare organizations across Europe
- This shift towards automation and increased accuracy in healthcare infrastructure is a driving force for the continued growth of the LIS market in Europe
Opportunity
“Increasing Emphasis on Digitization and Integration of Technology”
- The ongoing digital transformation in healthcare presents significant opportunities for the Europe Laboratory Information Systems (LIS) market
- Increasing emphasis on digitization and the integration of technology in healthcare operations has led to the rapid adoption of cloud-based LIS solutions
- Cloud technology offers benefits such as scalability, cost-effectiveness, and real-time data access from any location, which is essential in today’s fast-paced healthcare environment
- For instance, cloud-based LIS solutions provided by companies such as LabWare help hospitals and laboratories store patient data without the need for on-premise hardware, reducing operational costs
- Advancements in cloud infrastructure enable healthcare organizations to ensure data security while benefiting from more efficient data storage and management
- The European Union’s healthcare modernization initiatives and focus on improving healthcare IT infrastructure further support the growth of the LIS market
- These initiatives encourage the adoption of digital solutions such as LIS to enhance operational efficiency, reduce costs, and ensure compliance with stringent healthcare regulations across Europe
- As hospitals and laboratories increasingly embrace digital transformation, the demand for innovative, cloud-based LIS solutions is expected to rise, opening up new growth opportunities in the market
Restraint/Challenge
“High Implementation Cost”
- Despite the advantages of Laboratory Information Systems (LIS), several challenges hinder the market's growth in Europe
- One of the main restraints is the high implementation cost associated with these systems, particularly for smaller healthcare organizations and laboratories
- Smaller institutions often struggle with the financial burden of purchasing, maintaining, and updating LIS software, including expenses for staff training and system integration
- For instance, smaller hospitals may find it difficult to allocate funds for the full deployment of advanced LIS solutions, delaying their adoption
- Healthcare organizations also hesitate to adopt LIS solutions due to concerns about data security and compliance with stringent regulations such as the General Data Protection Regulation (GDPR)
- The rising number of cyberattacks targeting healthcare data increases fears about the safety of sensitive patient information, especially in cloud-based systems
- Overcoming these challenges requires substantial investments in cybersecurity measures and compliance protocols, which may be out of reach for some institutions, particularly smaller ones
- In addition, integrating LIS with existing healthcare systems, such as EHR or laboratory equipment, can be complex and time-consuming, increasing implementation costs further
Europe Laboratory Information Systems (LIS) Market Scope
The market is segmented on the basis of component, product, delivery, and end user.
|
Segmentation |
Sub-Segmentation |
|
ByComponent |
|
|
ByProduct |
|
|
ByDelivery |
|
|
ByEnd User |
|
In 2025, the cloud-based is projected to dominate the market with a largest share in delivery segment
The cloud-based segment is expected to dominate the Europe laboratory information Systems (LIS) market with the largest share of 44.3% in 2025 due to its scalability, cost-effectiveness, and the ability to provide real-time access to data from any location, which is crucial for the fast-paced healthcare environment.
The integrated Laboratory Information Systems (LIS) is expected to account for the largest share during the forecast period in product market
In 2025, the integrated Laboratory Information Systems (LIS) segment is expected to dominate the market with the largest market share of 68.5% due to its ability to provide a comprehensive solution that integrates various laboratory functions, patient data, and healthcare management systems into a single platform.
Europe Laboratory Information Systems (LIS) Market Regional Analysis
“Germany Holds the Largest Share in the Europe Laboratory Information Systems (LIS) Market”
- The Rhine-Main-Neckar region is recognized as one of the largest IT clusters in Europe, hosting major companies in software and technology, which contribute to the development and adoption of advanced LIS solutions
- The region is home to renowned research institutions such as the German Research Centre for Artificial Intelligence, fostering innovations in healthcare technologies, including laboratory information systems
- Its strong biopharmaceutical and fintech sectors rely on efficient data management solutions such as LIS to enhance operational capabilities and meet regulatory standards
- As Germany’s digital model city, Darmstadt in the region is committed to advancing digital healthcare infrastructure, which encourages the adoption of laboratory information systems within the healthcare sector
“Germany is Projected to Register the HighestCAGR in the Europe Laboratory Information Systems (LIS) Market”
- The region’s focus on digital transformation and innovation in healthcare technologies accelerates the growth of LIS adoption in Germany, making it the fastest-growing in Europe
- Government initiatives aimed at improving healthcare and digital infrastructure create a supportive environment for the growth of LIS
- High investments in healthcare IT and collaborations between private and public sectors provide strong opportunities for new, innovative LIS solutions
- The region’s robust healthcare system and technological advancements make it a key driver of rapid LIS market expansion in Europe
Europe Laboratory Information Systems (LIS) Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Compugroup Medical (Germany)
- Autoscribe (U.K.)
- Eusoft Ltd (Portugal)
- Perimed AB (Sweden)
- Perimed AB (Sweden)
- Carl Zeiss AG(Germany)
- Smith & Nephew(U.K.)
- CompuGroup Medical SE & Co. KGaA(Germany)
- Tecan Group Ltd. (Switzerland)
- Sartorius AG(Germany)
- STRATEC SE (Germany)
- CliniSys Group Ltd. (U.K.)
Latest Developments in Europe Laboratory Information Systems (LIS) Market
- In September 2024, Agilent Technologies completed the acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization specializing in biologics and highly potent active pharmaceutical ingredients. This strategic move enhances Agilent's Diagnostics and Genomics Group by expanding its contract development and manufacturing organization (CDMO) services, particularly in gene editing and targeted therapeutics. The acquisition strengthens Agilent's capabilities in cGMP pharmaceutical manufacturing, aligning with the growing demand for advanced therapeutics. This development is expected to bolster Agilent's position in the pharmaceutical market by offering comprehensive solutions that accelerate therapeutic programslink
- In July 2021, Francisco Partners, a global investment firm specializing in technology businesses, announced the acquisition of the STARLIMS informatics product suite and related business assets from Abbott Laboratories. This strategic move aims to enhance STARLIMS's capabilities in laboratory data and workflow management across various sectors, including life sciences, pharmaceuticals, and manufacturing. The acquisition is expected to accelerate STARLIMS's growth by supporting customers throughout the entire product lifecycle, from research and development to manufacturing and compliance. Francisco Partners plans to leverage its sectoral knowledge and operational expertise to further evolve STARLIMS's innovative product suite, meeting the evolving needs of its customers while maintaining industry-leading safety and compliance standards
- In July 2021, Francisco Partners, a global investment firm specializing in technology businesses, acquired the STARLIMS informatics product suite and related business assets from Abbott Laboratories. This acquisition aims to enhance STARLIMS's capabilities in laboratory data and workflow management across various sectors, including life sciences, pharmaceuticals, and manufacturing. The move is expected to support STARLIMS's growth by providing comprehensive solutions that span the entire product lifecycle, from research and development to manufacturing and compliance. Francisco Partners plans to leverage its sectoral knowledge and operational expertise to further evolve STARLIMS's innovative product suite, meeting the evolving needs of its customers while maintaining industry-leading safety and compliance standards
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 EINLEITUNG
1.1 ZIELE DER STUDIE
1.2 MARKET DEFINITION
1.3 ÜBERBLICK DES EUROPAS ARBEITSMARKTSYSTEME (LIS)
1.4 KURZ UND PREISUNG
1.5 LIMITATIONEN
1.6 MARKEITEN
2 MARKET SEGMENTATION
2.1 REGIERUNGEN
2.2 GEOGRAPHISCHE ANWENDUNGSBEREICH
2.3 JAHRE FÜR DIE STUDIE
2.4 DBMR TRIPOD DATENWERTUNG MODEL
2.5 PRIMARY INTERVIEWS MIT STELLUNGNAHMEN
2.6 MULTIVARIAT MODELLEN
2.7 MARKET ANWENDUNGSBEREICH
2.8 ERZEUGNISSE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSE
2.11 GERICHTSHOFES
2.12 VERBRAUCHUNGEN
3 ZUSAMMENFASSUNG
4 VORSCHRIFTEN
4.1 PORTER’s FIVE FORCES
4.2 PESTELANALYSE
5 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKT: VERORDNUNGEN
5.1 LEITLINIEN UND STANDARDS IN VEREINIGTEN STAATEN: U.S. LEBENSMITTEL UND DRUG VERWALTUNG (FDA)
6 MARKET ÜBERBLICK
6.1 DRIVERS
6.1.1 INKREISEN IN DER ANFORDERUNG VON QUICK-DECISIONSVERFAHREN IN BIOTECHNOLOGIE
6.1.2 RISING DEMAND FOR ADVANCED COMPUTATIONAL TOOLS IN FORARCH LABORATOR
6.1.3 RISIKOPOSITIONEN ZUR ZWISCHEN ZWISCHEN ZWISCHEN ZWECKE
6.1.4 INTEGRATION DER ADVANCED TECHNOLOGIES SUCH AS AI, MACHINE LEARNING
6.2 ENTWICKLUNGEN
6.2.1 HIGHER COST DER DATENVERWALTUNG & SOFTWARE
6.2.2 RÜCKSICHTIGUNG DER WELL-DEFINED STANDARD FORMAT FÜR DATEN INTEGRATION
6.2.3 STRINGENT VERORDNUNG NACH REGIERUNGSENTITÄTEN INFORMATIK DOMAIN
6.3 OPPORTUNITÄTEN
6.3.1 STRATEGISCHE ENTSCHEIDUNGEN
6.3.2 ZUSAMMENFASSUNGEN IN R&D LABS SPEZIALIEN IN PHARMACEUTICAL SECTOR
6.3.3 EINNAHMEN IN DER VERWALTUNGSINITIATIVEN VON REGIERUNGEN, da die PRIVATE SEKTOREN
6.4 HANDELN
6.4.1 VERWENDUNGSBEREICH UND ENTWICKLUNG DER ZUSAMMENARBEIT
6.4.2 DATA COMPLEXITY & LACK OF USER FRIENDLY TOOLS
7 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT, NACH WAREN
7.1 ÜBERBLICK
7.2 INTEGRATES LIS
7.3 STANDALONE LIS
8 EUROPA ARBEITSBEDINGUNGEN (LIS)
8.1 ÜBERBLICK
8.2 DIENSTLEISTUNG
8.3 SOFTWARE
8.3.1 VERWALTUNGSPROGRAMM
8.3.2 BERICHT ÜBER SOFTWARE
8.3.3 WORKFLOW MANAGEMENT SOFTWARE
8.3.4 EMR/EHR SOFTWARE
8.3.5 SONSTIGE SOFTWARE
9 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKT, NACH DELIVERY
9.1 ÜBERBLICK
9.2 KLOUD-BASED
9.3 REMOTELY-HOSTED
9.4 EINPREMISE
10 EUROPA LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, NACH END USER
10.1 ÜBERBLICK
10.2 HOSPITAL LABORATOREN
10.3 INDEPENDENT LABORATOREN
10.4 PHYSISCHE AMT LABORATOREN
10.5 SONSTIGE
11 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKET, NACH REGION
11.1 EUROPA
11.1.1 DEUTSCHLAND
11.1.2 FRANKREICH
11.1.3 U.K.
11.1.4 ITALIEN
11.1.5 SPANIEN
11.1.6 RUSSIEN
11.1.7 NIEDERLANDE
11.1.8 SCHWEIZ
11.1.9 BELGIEN
11.1.10 TURKEY
11.1.11 REST EUROPA
12 EUROPA LABORATORY INFORMATIONSSYSTEME (LIS) MARKET: COMPANY LANDSCAPE
12.1 WETTBEWERBSANALYSE: EUROPA
13 SCHLUSSANTRÄGE
14 COMPANY PROFIs
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 WETTBEWERBSPOLITIK
14.1.2 REVENTIONSANALYSE
14.1.3 WETTBEWERBSRECHT
14.1.4 PRODUKTPORTFOLIO
14.1.5 ENTWICKLUNG
14.2 ROPER TECHNOLOGIEN, INC.
14.2.1 WETTBEWERBSPOLITIK
14.2.2 REVENTIONSANALYSE
14.2.3 GESELLSCHAFTSRECHT
14.2.4 ERZEUGNISSE
14.2.5 ENTWICKLUNG
14.3 PERKINELMER INC
14.3.1 WETTBEWERBSPOLITIK
14.3.2 GESELLSCHAFTSRECHT
14.3.3 PRODUKTPORTFOLIO
ENTWICKLUNG DES GERICHTSHOFS
14.4 ILLUMINA INC.
14.4.1 WETTBEWERBSPOLITIK
14.4.2 REVENTIONSANALYSE
14.4.3 GEMEINSCHAFTSRECHTSSACHE
14.4.4 ERZEUGNISSE
14.4.5 RECENT DEVELOPTIONEN
14.5 TECHNOLOGIEN, INC.
14.5.1 WETTBEWERBSPOLITIK
ANALYSE
14.5.3 GEMEINSCHAFTSRECHTSSACHE
14.5.4 ERZEUGNISSE
ENTWICKLUNG
14.6 AGARAM TECHNOLOGIEN PVT LTD
14.6.1 Gegenleistung
14.6.2 ERZEUGNISSE
ENTWICKLUNGEN
14.7 AUTOSCRIBE INFORMATIK
14.7.1 WETTBEWERBSPOLITIK
14.7.2 ERZEUGNISSE
ENTWICKLUNGEN
14.8 BENCHLEN
14.8.1 VEREINIGTES NAPSHOT
14.8.2 ERZEUGNISSE
ENTWICKLUNG
14.9 VERWALTUNGSMITTEL
14.9.1 VEREINIGTES NAPSHOT
14.9.2 REVENUE ANALYSE
14.9.3 PRODUKTPORTFOLIO
ENTWICKLUNG DES GERICHTSHOFS
14.9.5 CLINISYS
14.9.6 VERGLEICH SNAPSHOT
1.1.4 ERZEUGNISSE 131
ENTWICKLUNG
14.1 EPIC SYSTEME CORPORATION
14.10.1 WETTBEWERBSPOLITIK
14.10.2 ERZEUGNISSE
ENTWICKLUNGEN
14.11 EUSOFT
14.11.1 VEREINIGTES SNAPSHOT
14.11.2 ERZEUGNISSE
ENTWICKLUNG DES GERICHTSHOFES
14.12 INFORS AG
14.12.1 WETTBEWERBSPOLITIK
14.12.2 ERZEUGNISSE
ENTWICKLUNG DES GERICHTSHOFES
14.13 KRITILIMS.IN
14.13.1 WETTBEWERBSPOLITIK
14.13.2 PRODUKTPORTFOLI
ENTWICKLUNG
14.14 LABSOLEN
14.14.1 COMPANY SNAPSHOT
14.14.2 ERZEUGNISSE
ENTWICKLUNG
14.15 ENTWICKLUNGEN INC.
14.15.1 VERGLEICHEN SNAPSHOT
14.15.2 ERZEUGNISSE
ENTWICKLUNG
14.16 LQS
14.16.1 GESUNDHEITSSCHUTZ
14.16.2 ERZEUGNISSE
14.16.3 ENTWICKLUNGEN
14.17 MCKESSON CORPORATION
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSE
14.17.3 ERZEUGNISSE
14.17.4 RECENT ENTWICKLUNG
14.18 NOVATE
14.18.1 VEREINIGTES NAPSHOT
14.18.2 ERZEUGNISSE
14.18.3 RECENT ENTWICKLUNG
14.19 SCHIMADZU ZUSAMMENARBEIT
14.19.1 GESUNDHEITSSCHUTZ
14.19.2 REVENUE ANALYSE
14.19.3 ERZEUGNISSE
14.19.4 RECENT ENTWICKLUNG
14.2 SIEMENS AG
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENTIONSANALYSE
14.20.3 ERZEUGNISSE
ENTWICKLUNG
14.21 STARLIMS CORPORATION
14.21.1 WETTBEWERBSPOLITIK
14.21.2 ERZEUGNISSE
ENTWICKLUNG
15 QUESTIONNAIRE
16 BERICHTE
Tabellenverzeichnis
TABELLE 1 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 2 EUROPA INTEGRATED LIS IN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABELLE 3 EUROPA STANDALONE LIS IN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 4 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 5 EUROPA DIENSTLEISTUNG IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABELLE 6 EUROPA SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 7 EUROPA SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 8 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKET, NACH DELIVERY, 2022-2031 (USD MILLION)
TABELLE 9 EUROPA ARBEITSLOSIGKEIT IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 10 EUROPA IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 11 EUROPA IN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 12 EUROPA ARBEITNEHMERSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 13 EUROPA HOSPITAL LABORATOREN IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABELLE 14 EUROPA INDEPENDENT LABORATOREN IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 15 EUROPA PHYSIKISCHE AMT FÜR ARBEITSBEDINGUNGEN IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, NACH REGION, 2022-2031 (USD MILLION)
TABELLE 16 EUROPA SONDERE IN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABELLE 17 EUROPA ARBEITNEHMERSYSTEME (LIS) MARKT, NACH LAND, 2022-2031 (USD MILLION)
TABELLE 18 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKET, NACH COMPONENT, 2022-2031 (USD MILLION)
TABELLE 19 EUROPA SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 20 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 21 EUROPA ARBEITNEHMERSYSTEME (LIS) MARKT, NACH DELIVERY, 2022-2031 (USD MILLION)
TABELLE 22 EUROPA ARBEITNEHMERSYSTEME (LIS) MARKET, NACH END USER, 2022-2031 (USD MILLION)
TABELLE 23 GERMANY LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 24 GERMANY SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 25 GERMANY LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 26 GERMANY LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 27 GERMANY LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 28 FRANKREICH INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 29 FRANKREICH SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 30 FRANKREICH INFORMATIONSSYSTEME (LIS) MARKET, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 31 FRANKREICH INFORMATIONSSYSTEME (LIS) MARKET, NACH DELIVERY, 2022-2031 (USD MILLION)
TABELLE 32 FRANKREICH ARBEITSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 33 U.K. LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 34 U.K. SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 35 U.K. LABORATORY INFORMATIONSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 36 U.K. LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 37 U.K. LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 38 ITALIEN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 39 ITALIENES SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 40 ITALIEN RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 41 ITALIEN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 42 ITALIEN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 43 SPANIEN ARBEITSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 44 SPANIEN IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 45 SCHLUSSBILDUNGSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 46 SPANIEN ARBEITSSYSTEME (LIS) MARKET, NACH DELIVERY, 2022-2031 (USD MILLION)
TABELLE 47 SPANIEN ARBEITSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 48 RUSSIA LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 49 RUSSIA SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 50 RUSSIA LABORATORY INFORMATIONSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 51 RUSSIA LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 52 RUSSIA LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 53 NIEDERLANDE LABORATORIE INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 54 NIEDERLANDE SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 55 NIEDERLANDE LABORATORIE INFORMATIONSSYSTEME (LIS) MARKT, NIE PRODUKTE, 2022-2031 (USD MILLION)
TABELLE 56 NIEDERLANDE LABORATORIE INFORMATIONSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 57 NIEDERLANDE LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 58 SCHWEIZ LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 59 SCHWEIZ SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 60 SCHWEIZ LABORATORIE INFORMATIONSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 61 SCHWEIZ LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 62 SCHWEIZ LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 63 BELGIEN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 64 BELGIUM SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 65 BELGIEN ARBEITSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 66 BELGIEN ARBEITSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 67 BELGIEN LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 68 TÜRKEY LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 69 TURKEY SOFTWARE IN LABORATORY INFORMATIONSSYSTEMEN (LIS) MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABELLE 70 ENTWICKLUNGSSYSTEME (LIS) MARKT, NACH PRODUKT, 2022-2031 (USD MILLION)
TABELLE 71 ENTWICKLUNGSSYSTEME (LIS) MARKET, BY DELIVERY, 2022-2031 (USD MILLION)
TABELLE 72 TÜRKEY LABORATORY INFORMATIONSSYSTEME (LIS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABELLE 73 REST of EUROPE ARBEITSSYSTEME (LIS) MARKT, NACH COMPONENT, 2022-2031 (USD MILLION)
Abbildungsverzeichnis
VERWALTUNGSSYSTEME (LIMS) MARKT: REGIERUNG
Abbildung 2 EUROPA RECHTLICHE INFORMATIONSSYSTEME (LIS) MARKT: DATEN
Abbildung 3 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: DROK ANALYSE
SCHAUBILD 4 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: EUROPA VS REGIONALMARKT ANALYSE
Abbildung 5 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: GESUNDHEITSSCHÄFTIGUNG
Abbildung 6 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: INTERVIEW DEMOGRAPHICS
Abbildung 7 EUROPA ARBEITSLOSIGKEITSSYSTEME (LIS) MARKT: MARKET ANWENDUNG DER REGIERUNGSGRID
Abbildung 8 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: DBMR MARKET POSITION GRID
Abbildung 9 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: VENDOR SHARE ANALYSE
Abbildung 10 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT: REGIERUNG
ZUSAMMENFASSUNG 11 ZWISCHEN ZWISCHEN ZWISCHEN ZWISCHEN ZWISCHEN INFORMATIONSSYSTEMEN (LIS) MARKT, NACH BESTANDTEILE
ZUSAMMENFASSUNG 12
Abbildung 13 STRATEGISCHE ENTSCHEIDUNG
Abbildung 14 ENTWICKLUNGSPROZESS IN BIOTECHNOLOGIE ZUR GLEICHBEHANDLUNG DER RECHTSSACHE DER RECHTSAKTE DER ARBEITSMARKT IN EUROPA
Abbildung 15 DIENSTLEISTUNGSBILANZEN FÜR DIE LARGESTÄTZE DER EUROPAISCHEN RECHTLICHEN INFORMATIONSSYSTEME (LIS) MARKT IN 2024 UND 2031
Abbildung 16 VERWENDUNGSBEREICH, ERGEBNISSE, OPPORTUNITÄTEN, KALLE FÜR EUROPA
Abbildung 17 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT: NACH WAREN, 2023
Abbildung 18 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH PRODUKT, 2024-2031 (USD MILLION)
Abbildung 19 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH PRODUKT, CAGR (2024-2031)
Abbildung 20 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT: NACH PRODUKT, LEBENLINIEN
Abbildung 21 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT: BY COMPONENT, 2023
Abbildung 22 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH COMPONENT, 2024-2031 (USD MILLION)
Abbildung 23 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH COMPONENT, CAGR (2024-2031)
Abbildung 24 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT: BY COMPONENT, LIFELINE URVE
Abbildung 25 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH DELIVERY, 2023
Abbildung 26 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH DELIVERY, 2024-2031 (USD MILLION)
Abbildung 27 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH DELIVERY, CAGR (2024-2031)
Abbildung 28 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH DELIVERY, LIFELINE URVE
SCHAUBILD 29 EUROPA ARBEITNEHMERSYSTEME (LIS) MARKT: BY END USER, 2023
Abbildung 30 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: NACH END USER, 2024-2031 (USD MILLION)
SCHAUBILD 31 EUROPA ARBEITNEHMERSYSTEME (LIS) MARKT: BY END USER, CAGR (2024-2031)
Abbildung 32 EUROPA ARBEITSBEDINGUNGEN SYSTEME (LIS) MARKT: NACH END USER, LIFELINE URVE
Abbildung 33 EUROPA ARBEITSMARKTSYSTEME (LIS) MARKT: SNAPSHOT (2023)
SCHAUBILD 34 EUROPA ARBEITSBEDINGUNGEN (LIS) MARKT: GESUNDHEITSSCHUTZ 2023 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
